References
- Claus E B, Risch N, Thompson W D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232–42
- Lynch H T, Marcus M M, Watson P, Conway T, Fitzsimmons M L, Lynch J F. Genetic epidemiology of breast cancer. Genetic epidemiology of cancer, H T Lynch, T Hirayama. CRC press Inc., Boca Raton, Florida 1989; 289–332, edited by HT Lynch, T Hirayama, pp. 289–332
- Knudsen A G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820–3
- Grompe M. The rapid detection of unknown mutations in nucleic acids. Nature Genet. 1993; 5: 111–7
- Hall J M, Lee M K, Newman B. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9
- Narod S A, Feunteun J, Lynch H T. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991; 2: 82–3
- Easton D F, Bishop D T, Ford D, Crockford G P, the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer—results from 214 families. Am J Hum Genet 1993; 52: 678–701
- Miki Y, Swenson J, Shattuck-Eidens D. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71
- Shattuck-Eidens D, McClure M, Simard J. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 1995, in press
- Brown M A, Nicolai H, Xu C-F. Regulation of BRCA1. Nature 1994; 372: 733
- Futreal P A, Liu Q, Shattuck-Eidens D. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120–2
- Thompson M E, Jensen R A, Obermiller P S, Page D L, Holt J T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 1995; 9: 444–50
- Wooster R, Neuhausen S L, Mangion J. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 1994; 265: 2088–90
- Friedman L S, Ostermeyer E A, Lynch E D. The search for BRCA1. Cancer Res. 1994; 54: 6374–82
- Schott D R, Chang J N, Deng G. A candidate tumor suppressor gene in human breast cancer. Cancer Res 1993; 54: 1393–6
- Malkin D, Li F P, Strong L C, Fraumeni J F, Jr. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250: 1233–8
- Zuppan P, Hall J M, Lee M K, Ponglikitmongkol M., King M-C. Possible linkage of the estrogen receptor gene to breast cancer in a family with late onset disease. Am J Hum Genet 1991; 48: 1065–8
- Milner B J, Allan L A, Kelly K F. Linkage studies with 17q and 18q markers in a breast ovarian cancer family. Am J Hum Genet 1993; 53: 761–6
- Kerangueven F, Essioux L, Dib A. Loss of heterozygos-ity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 1995
- Wooster R, Mangion J, Eeles R. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 1992; 2: 132–4
- Savitsky K, Bar-Shira A, Gilad S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749–53
- Wooster R, Ford D, Mangion J. Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. Hum Genet 1993; 92: 1–94